May 23, 2025
Harrington Discovery Institute at University Hospitals Holds 12th Annual Scientific Symposium CLEVELAND, Ohio, US, May 23, 2025–Harrington Discovery Institute at University Hospitals held its 12th annual scientific symposium this week. Scientific researchers and leaders from across the globe gathered in Cleveland, Ohio...
Continue ReadingMay 01, 2023
Atsena Therapeutics announced that the FDA has cleared the company’s IND application for a Phase I/II clinical trial of ATSN-201 in patients with X-linked retinoschisis (XLRS), featuring Harrington Scholar Shannon Boye, PhD, University of Florida. Continue Reading
April 26, 2023
10 physician-scientists have been selected for drug development grant to advance discoveries into the clinic Continue Reading
April 14, 2023
Researchers have found a promising new method for delivering oxygen to tissues damaged by disease by coupling nitric oxide, which dilates blood vessels, with the oxygen carrying molecule hemoglobin to help people living with a number of diseases. Continue Reading
April 12, 2023
Harrington Scholar Dr. Khvorova and research team have developed a technology to deliver gene therapy directly to lung tissue through intranasal administration, a development that could potentially create a new class of treatments for lung disease. Continue Reading
April 10, 2023
Unique program for physician-scientists to advance promising discoveries into medicines Continue Reading
April 03, 2023
Focus on glymphatic clearance, neurovascular health, and other novel approaches Continue Reading
March 07, 2023
2023 Harrington Prize for Innovation in Medicine Recognizes Pioneering Work in Retinal Gene Therapy for Genetic Diseases Continue Reading
March 01, 2023
Newfound clarity on the longstanding “medical mystery” may lead to new line of drugs for oxygen delivery disorders, including peripheral artery disease, sickle cell disease, heart failure, and others Continue Reading
February 23, 2023
UVA Health School of Medicine scientists have discovered an unknown contributor to harmful blood vessel growth in the eye that could lead to new treatments for blinding macular degeneration and other common causes of vision loss. Continue Reading
February 14, 2023
Studies published from researchers at the biotech startup AcuraStem and the University of Southern California validated two potential drug targets in animal models of both genetic and sporadic ALS, paving the way for broad treatments. Continue Reading